Johnson & Johnson appoints new Executive Vice President, Pharmaceuticals, R&D
European Pharmaceutical Review
FEBRUARY 14, 2023
Johnson & Johnson ( J&J ) has announced that Dr John Reed, PhD, will become the company’s Executive Vice President of Pharmaceuticals, R&D on April 3, 2023. to the Company’s Executive Committee as Executive Vice President of Pharmaceuticals, R&D. Johnson & Johnson today announced the appointment of John Reed, M.D.,
Let's personalize your content